Collins, a renowned geneticist and former longtime director of the National Institutes of Health, announced Saturday that he ...
Former National Institutes of Health Director Francis Collins unexpectedly retired on Friday, writing in a statement that ...
Take CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA), two biotechs specializing in gene editing. Finance, is $83.60; the latter earns a price target of $50.80 from ...
Rather than being famous only in the gene editing field, by revealing the collateral cleavage activity of Cas12a, Cas13a, and Cas14 effectors, Clustered Regularly Interspaced Short Palindromic Repeats ...
By Matt Bell Our columnist reviews three new horror books out this month. By Gabino Iglesias ...
These classic books predicted the future with eerie accuracy, from mass surveillance to social isolation. Their warnings are ...
Whether you're looking for a classic or the latest and greatest, start here. By The New York Times Books Staff Here are the year’s notable fiction, poetry and nonfiction, chosen by the staff ...
After hours: 7:57:54 p.m. EST ...